FDA expands ibrutinib indications to chronic GVHD
admin 28th August 2017 Uncategorised 0European Society for Medical Oncology News
More: FDA expands ibrutinib indications to chronic GVHD
Source: MDlinx
European Society for Medical Oncology News
More: FDA expands ibrutinib indications to chronic GVHD
Source: MDlinx
© 1994 - 2024 B.M. Pharmaceuticals